Photo by impulsq from unsplash
Purinergic modulators, such as dipyridamole, target multiple pathways that have been implicated in COVID-19 pathogenesis, and thus the therapeutic benefit of these should be explored. Click to show full abstract
Purinergic modulators, such as dipyridamole, target multiple pathways that have been implicated in COVID-19 pathogenesis, and thus the therapeutic benefit of these should be explored.
Keywords:
drug purinergic;
old drug;
receptor blockade;
purpose old;
purinergic receptor;
new purpose
Journal Title: JCI insight
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JCI insight
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!